Donald L Bissett

Summary

Affiliation: The Procter and Gamble Company
Country: USA

Publications

  1. ncbi Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine
    Donald L Bissett
    Procter and Gamble Company, Cincinnati, Ohio 45252, USA
    J Cosmet Dermatol 6:20-6. 2007
  2. ncbi Glucosamine: an ingredient with skin and other benefits
    Donald L Bissett
    Procter and Gamble Co, Miami Valley Laboratories, Cincinnati, OH 45252, USA
    J Cosmet Dermatol 5:309-15. 2006
  3. doi Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin
    D L Bissett
    The Procter and Gamble Company, Cincinnati, OH, USA
    Int J Cosmet Sci 26:231-8. 2004
  4. ncbi Niacinamide: A B vitamin that improves aging facial skin appearance
    Donald L Bissett
    The Procter and Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio 45252, USA
    Dermatol Surg 31:860-5; discussion 865. 2005
  5. ncbi Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro
    Donald L Bissett
    Procter and Gamble Company, Cincinnati, OH, USA
    J Cosmet Dermatol 6:232-8. 2007
  6. doi Common cosmeceuticals
    Donald L Bissett
    The Procter and Gamble Company, Miami Valley Laboratories, Cincinnati, OH 45252, USA
    Clin Dermatol 27:435-45. 2009
  7. doi Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide
    Donald L Bissett
    The Procter and Gamble Company, Cincinnati, OH, USA
    J Cosmet Dermatol 8:260-6. 2009
  8. doi Latest insights into skin hyperpigmentation
    Jean Paul Ortonne
    Department of Dermatology, Hospital L Archet, University of Nice Sophia Antipolis, Nice, France
    J Investig Dermatol Symp Proc 13:10-4. 2008

Detail Information

Publications8

  1. ncbi Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine
    Donald L Bissett
    Procter and Gamble Company, Cincinnati, Ohio 45252, USA
    J Cosmet Dermatol 6:20-6. 2007
    ....
  2. ncbi Glucosamine: an ingredient with skin and other benefits
    Donald L Bissett
    Procter and Gamble Co, Miami Valley Laboratories, Cincinnati, OH 45252, USA
    J Cosmet Dermatol 5:309-15. 2006
    ..The current clinical uses for topical and oral glucosamine compounds and the mechanistic rationale for these uses are reviewed here...
  3. doi Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin
    D L Bissett
    The Procter and Gamble Company, Cincinnati, OH, USA
    Int J Cosmet Sci 26:231-8. 2004
    ..In addition, skin yellowing (sallowness) versus control was significantly improved. The mechanism by which this array of benefits is achieved with niacinamide is discussed...
  4. ncbi Niacinamide: A B vitamin that improves aging facial skin appearance
    Donald L Bissett
    The Procter and Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio 45252, USA
    Dermatol Surg 31:860-5; discussion 865. 2005
    ....
  5. ncbi Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro
    Donald L Bissett
    Procter and Gamble Company, Cincinnati, OH, USA
    J Cosmet Dermatol 6:232-8. 2007
    ..Thus, there are several mechanisms that may be operative in the observed pigmentation effects...
  6. doi Common cosmeceuticals
    Donald L Bissett
    The Procter and Gamble Company, Miami Valley Laboratories, Cincinnati, OH 45252, USA
    Clin Dermatol 27:435-45. 2009
    ..In particular, this contribution concentrates on those materials for which there are available clinical data that support a reported skin appearance improvement effect...
  7. doi Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide
    Donald L Bissett
    The Procter and Gamble Company, Cincinnati, OH, USA
    J Cosmet Dermatol 8:260-6. 2009
    ..Since these two agents function by different mechanisms, we conducted two studies to determine if their combination is more effective than niacinamide alone in reducing facial hyperpigmentation...
  8. doi Latest insights into skin hyperpigmentation
    Jean Paul Ortonne
    Department of Dermatology, Hospital L Archet, University of Nice Sophia Antipolis, Nice, France
    J Investig Dermatol Symp Proc 13:10-4. 2008
    ..Combined with a clear consumer need for effective pigmentation control agents, advanced pigmentary system understanding and new research capabilities are setting the stage for future technological advancements...